Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

被引:104
|
作者
Falcone, Marco [1 ]
Tiseo, Giusy [1 ]
Giordano, Cesira [2 ]
Leonildi, Alessandro [1 ]
Menichini, Melissa [2 ]
Vecchione, Alessandra [2 ]
Pistello, Mauro [3 ,4 ]
Guarracino, Fabio [5 ]
Ghiadoni, Lorenzo [6 ]
Forfori, Francesco [7 ]
Barnini, Simona [2 ]
Menichetti, Francesco [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Infect Dis Unit, Pisa, Italy
[2] Azienda Osped Univ Pisana, Microbiol Unit, Pisa, Italy
[3] Univ Pisa, Virol Unit, Dept Lab Med, Pisa Univ Hosp, Pisa, Italy
[4] Univ Pisa, Retrovirus Ctr, Dept Translat Res, Pisa, Italy
[5] Azienda Osped Univ Pisana, Dept Anaesthesia & Crit Care Med, Pisa, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Emergency Med Unit, Pisa, Italy
[7] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care Med, Pisa, Italy
关键词
D O I
10.1093/jac/dkaa530
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bacterial and fungal superinfections may complicate the course of hospitalized patients with COVID-19. Objectives: To identify predictors of superinfections in COVID-19. Methods: Prospective, observational study including patients with COVID-19 consecutively admitted to the University Hospital of Pisa, Italy, between 4 March and 30 April 2020. Clinical data and outcomes were registered. Superinfection was defined as a bacterial or fungal infection that occurred >= 48 h after hospital admission. A multivariate analysis was performed to identify factors independently associated with superinfections. Results: Overall, 315 patients with COVID-19 were hospitalized and 109 episodes of superinfections were documented in 69 (21.9%) patients. The median time from admission to superinfection was 19 days (range 11-29.75). Superinfections were caused by Enterobacterales (44.9%), non-fermenting Gram-negative bacilli (15.6%), Gram-positive bacteria (15.6%) and fungi (5.5%). Polymicrobial infections accounted for 18.3%. Predictors of superinfections were: intestinal colonization by carbapenem-resistant Enterobacterales (OR 16.03, 95% CI 6.5-39.5, P< 0.001); invasive mechanical ventilation (OR 5.6, 95% CI 2.4-13.1, P< 0.001); immunomodulatory agents (tocilizumab/baricitinib) (OR 5.09, 95% CI 2.2-11.8, P< 0.001); C-reactive protein on admission >7 mg/dl (OR 3.59, 95% CI 1.7-7.7, P= 0.001); and previous treatment with piperacillin/tazobactam (OR 2.85, 95% CI 1.1-7.2, P= 0.028). Length of hospital stay was Longer in patients who developed superinfections ompared with those who did not (30 versus 11 days, P< 0.001), while mortality rates were similar (18.8% versus 23.2%, P= 0.445). Conclusions: The risk of bacterial and fungal superinfections in COVID-19 is consistent. Patients who need empiric broad-spectrum antibiotics and immunomodulant drugs should be carefully selected. Infection control rules must be reinforced.
引用
收藏
页码:1078 / 1084
页数:7
相关论文
共 50 条
  • [21] COVID-19 and Hospital-Acquired Pressure Injuries: A Systematic Review
    Bourkas, Adrienn N.
    Zaman, Michele
    Sibbald, R. Gary
    ADVANCES IN SKIN & WOUND CARE, 2023, 36 (08) : 421 - 434
  • [22] Hospital-acquired infective endocarditis during Covid-19 pandemic
    Ramos-Martinez, Antonio
    Fernandez-Cruz, Ana
    Dominguez, Fernando
    Forteza, Alberto
    Cobo, Marta
    Sanchez-Romero, Isabel
    Asensio, Angel
    INFECTION PREVENTION IN PRACTICE, 2020, 2 (03)
  • [23] Hospital-acquired hyponatremia in postoperative pediatric patients: Prospective observational study
    Eulmesekian, Pablo G.
    Perez, Augusto
    Minces, Pablo G.
    Bohn, Desmond
    PEDIATRIC CRITICAL CARE MEDICINE, 2010, 11 (04) : 479 - 483
  • [24] Hospital-acquired infections during COVID-19 pandemic: Correspondence
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (5-6) : 138 - 139
  • [25] Etiology of community-acquired and hospital-acquired pneumonia associated with COVID-19
    Chemisova, O.
    Noskov, A.
    Pavlovich, N.
    Aronova, N.
    Vodopianov, S.
    Gayevskaya, N.
    Kovalev, E.
    Gudueva, E.
    Pshenichnaya, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S39 - S39
  • [26] Impact of coronavirus disease 2019 (COVID-19) pandemic in hospital-acquired infections and bacterial resistance at an oncology hospital
    Cornejo-Juarez, Patricia
    Volkow-Fernandez, Patricia
    Vazquez-Marin, Carla L.
    Alvarez-Romero, Nancy
    Garcia-Pineda, Bertha
    Chavez-Chavez, Tania
    Vilar-Compte, Diana
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [27] Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study
    Anselm Jorda
    Cornelia Gabler
    Amelie Blaschke
    Michael Wölfl-Duchek
    Georg Gelbenegger
    Alina Nussbaumer-Pröll
    Christine Radtke
    Markus Zeitlinger
    Felix Bergmann
    Infection, 2024, 52 : 105 - 115
  • [28] Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study
    Jorda, Anselm
    Gabler, Cornelia
    Blaschke, Amelie
    Woelfl-Duchek, Michael
    Gelbenegger, Georg
    Nussbaumer-Proell, Alina
    Radtke, Christine
    Zeitlinger, Markus
    Bergmann, Felix
    INFECTION, 2024, 52 (01) : 105 - 115
  • [29] The controversial bond between COVID-19 and bacterial superinfections
    Bonazzetti, Cecilia
    Giannella, Maddalena
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 411 - 413
  • [30] Correction to: The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
    Chaitanya Tellapragada
    Christian G. Giske
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2487 - 2488